Medtronic plans to acquire SPR Therapeutics in a $650 million deal, according to a May 20 news release. SPR Therapeutics focuses on percutaneous peripheral nerve stimulation for chronic pain ...

Kweli Thompson will be promoted to head of Medtronic’s neuroscience portfolio, and Peter Menziuso will join BD’s ...

Medtronic Neurovascular announced that its Onyx Liquid Embolic System (LES), Onyx 18 and Onyx 34, received FDA approval for a shake ...

Medtronic will acquire SPR Therapeutics for $650 million, adding the FDA-cleared SPRINT PNS System for temporary PNS to its ...

Medtronic is reportedly planning to cease operations at its facility in Santa Rosa, California, amid reports of layoffs and ...

Medical device giant Medtronic disclosed last week that hackers breached its network and accessed data in “certain corporate IT systems.” The confirmation comes after the infamous data extortion group ...

Medtronic, the largest medical device maker in the world, said it contained a cyberattack on its corporate IT systems and that the breach didn’t impact any of its products or patients. The attack is ...

Medical device giant Medtronic has confirmed a data security incident affecting its corporate IT systems following claims by a cybercrime group that millions of records were stolen. The company said ...

Medical device giant Medtronic confirmed over the weekend that its systems had been hacked by an unauthorized party. Here are six things to know about the cyberattack. —Medtronic said that the ...

April 27 (Reuters) - Medical device maker Medtronic (MDT.N), opens new tab said on Monday a cyberattack on its computer systems last week did not affect its products or ability ‌to meet patient needs, ...

Medtronic is a diversified MedTech company undergoing business simplification and cost improvements, with a focus on margin recovery over high growth. MDT trades at a discount to peers, reflecting ...

April 27 (Reuters) - Medical device maker ⁠Medtronic ⁠said on Monday ⁠a cyberattack on its computer systems last week did not affect its products or ability to ‌meet patient needs, and ‌is not ...